Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Esoteric Testing Market Size to Reach USD 56.44 Billion in 2030 | Emergen Research

This image opens in the lightbox

News provided by

Emergen Research

07 Feb, 2023, 18:12 GMT

Share this article

Share toX

Share this article

Share toX

VANCOUVER, BC, Feb. 7, 2023 /PRNewswire/ -- The esoteric testing market size reached USD 20.85 Billion in 2021 and is expected to register a CAGR of 11.7% during the forecast period, according to latest analysis by Emergen Research. Increasing initiatives by various organizations in the region to conduct research on orphan drugs to redress rare diseases is the key factor driving market revenue growth.

One of the main factors driving the market's revenue growth is the rising prevalence of infectious and chronic diseases. The World Health Organization (WHO) estimates that 1.6 million people worldwide died from TB in 2021. The rising incidence of chronic diseases presents a significant opportunity for cutting-edge research into unique molecules that can be altered to create novel medications.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1534

Another factor driving revenue growth is the growing number of successful research and development outcomes in the area of cellular immunology that are used to treat conditions like cardiovascular disease, adenocarcinomas, and neurological illnesses, among others. The majority of cases of Parkinson's disease (PD) are spontaneous and have no known cause. Following substantial continued efforts, the pathogenic mechanisms causing PD are largely unclear.

Drivers:

Increase in prevalence of chronic and contagious diseases, development of novel genetic sequencing techniques for focused therapy, early tumor detection, and targeted therapeutics are the major factors driving revenue growth. The global spread of non-communicable diseases such as diabetes, heart failure, and cancer is growing rapidly. At the same time, the incidence of infectious diseases like Hepatitis B, Malaria, Dengue, AIDS, and Tuberculosis is also on the rise. Increasing need for effective and rapid diagnosis is driving the development of exotic diagnostic tests. The development of esoteric test technology has led to improvements in performance speed, accuracy, and efficacy. The market growth is being fueled by advancements in technology, such as the use of whole functional genomics, next-generation sequencing techniques, and specialized genetic analysis for cancer detection and targeted therapy, as well as personalized medicine. New DNA profiling methods are being created for early cancer diagnosis, targeted therapy, and the assessment of the frequency, impact, and lifespan of chronic diseases.

Restraints:

Inadequate remuneration is one of the key restraints preventing the esoteric diagnostic industry from growing its market revenue. Private insurance companies rarely reimburse for individualized and therapeutic procedures. A reduction in the payments for screening procedures has already had a significant impact on the volume of testing in recent years. As a result, organizations that pay for healthcare, insurance, and other services are created, and their limits on using clinical laboratories are tightened.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1534

Growth Projections:      

The esoteric testing market is expected to register a CAGR of 11.7% over the forecast period and revenue is projected to increase from USD 20.85 Billion in 2021 to USD 56.44 Billion in 2030. Increasing number of research and development activities conducted by the market players is expected to lead to novel product launches that are FDA-approved.

Current Trends and Innovations:

The market is predicted to expand owing to advancements in technology like recent study techniques in morphological characteristics, pyrosequencing, digital PCR, genotyping, and genome sequencing, as well as advancements in diagnostic research. The major players in the exotic diagnostics market are poised for potential growth in the future, particularly in developing countries such as China, India, and others. This is due to an aging population, a growing number of parasitic disorders, improvements in healthcare systems, and an increase in disposable income in these countries.

Digitalized PCR, genomic testing, next-generation sequencing, and other advancements in genetic morphological traits are some of the technological developments that are expected to drive the market revenue growth in the industry. Market players in the specialized screening industry can benefit from the opportunities offered by growing countries such as China, India, and other countries.

Strategic Initiatives:

Major companies included in the market report are Laboratory Corporation of America; OPKO Health, Inc.; H.U. Group Holdings, Inc.; Nordic Lifesciences; Genomic Health, Inc.; American Medical Lab.; Invitae Corporation; SYNLAB International GmbH.; UNILABS; and Fulgent Genetics.

  • On October 20, 2022, BioGX, a global provider of simple molecular diagnostic solutions, announced the availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on a variety of real-time PCR platforms, including BioGX's quick "pixl" platform, to address the growing demand for streamlined, quick testing for monkeypox.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/esoteric-testing-market

Scope of Research

Report Details

Outcome

Market size in 2021

USD 20.85 Billion

CAGR (2022–2030)

11.7 %

Revenue forecast to 2030

USD 56.44 Billion

Base year for estimation

2021

Historical data

2019–2020

Forecast period

2022–2030

Quantitative units

Revenue in USD Billion and CAGR in % from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, Techniques, and region

Regional scope

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Country scope

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, U.A.E., South Africa, Turkey, and Rest of MEA

Key companies profiled

Laboratory Corporation of America, OPKO Health, Inc., H.U. Group Holdings, Inc., Nordic Lifesciences, Genomic Health, Inc.; American Medical Lab, Invitae Corporation, SYNLAB International GmbH, UNILABS, and Fulgent Genetics

Customization scope

10 hours of free customization and expert consultation

Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/1534

Emergen Research has segmented the esoteric testing market on the basis of type, techniques, and region:

  • Type Outlook (Revenue, USD Billion; 2019-2030)
    • Infectious Diseases Testing
    • Oncology testing
    • Immunology Testing
    • Others
  • Techniques Outlook (Revenue, USD Billion; 2019-2030)
    • ELISA
    • Flow Cytometry
    • Real Time - PCR
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019-2030)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC
    • Latin America
      • Brazil
      • Rest of LATAM
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Turkey
      • Rest of MEA

Latest Research Reports Published by Emergen Research:

Enterprise Information Archiving Market, By Type (Content Type, Services), By Deployment Mode, By Vertical, (Government and Defense, Banking and Financial Services, Retail and E-commerce, Other Verticals), By Region Forecast to 2032

Veterinary Anesthesia Equipment Market, By Product (Standalone Anesthesia Machines, Portable Anesthesia Machines, Vaporizers, and Others), By Animal Type (Small and Large), By End-Use, and By Region Forecast to 2032

Lyme Disease Treatment Market, By Treatment Type (Medication and Tick Removal), By Administration Route (Oral, Injectable, and Topical), By Distribution Channel (Hospital, Retail, and Online), By Application, and By Region Forecast to 2032

Animal Microchip Implant Market, By Product Type (Animal ID Microchip, Reusable Pet Tracking Microchip, Transponder Microchips, Others), By Mode (Self-injectable, Surgery-injectable), By End-use, By Region Forecast to 2032

Contrast Media Market, By Modality [Computed Topography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound], By Application [Cardiovascular Disorders (CVD), Neurological Disorders, and Cancer], and By Region Forecast to 2032

Polyacrylic Acid Market, By Type (CoPolymer, HomoPolymer, and TerPolymer), By Grade (Industrial Grade, Cosmetic Grade, and Pharmaceutical Grade), By Physical State, By Application, By End-Use, and By Region Forecast to 2032

Flocculants Market, By Type (Synthetic Flocculants, Natural Flocculants, and Mineral Flocculants), By Category (Anionic, Cationic, Non-Ionic, and Others), By End-Use (Wastewater Treatment, Textile, and Paper), and By Region Forecast to 2032

Smart Television Market, By Operating System (Android TV, Tizen, Roku, WebOS, Others), By Resolution (4K UHD TV, HDTV, Full HD, 8K TV), By Screen Size, By Screen Type (Flat, Curved) By Region Forecast to 2032

Industrial Automation Market, By Component (Hardware, Software, Services), By Industry Vertical (Oil & Gas, Manufacturing, Automotive, Healthcare, Energy & Power, Others) By Region Forecast to 2032

Automotive Charge Air Cooler Market, By Vehicle Type (Light Commercial Vehicle, Heavy Commercial Vehicle, and Others), By Product Type (Liquid-Cooled and Air-Cooled), By Position, By Fuel Type, By Design, and By Region Forecast to 2032

About Emergen Research 

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend's existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read our Press Release @ https://www.emergenresearch.com/press-release/global-esoteric-testing-market
Trending Titles LiDAR Market | Metaverse Market

Logo: https://mma.prnewswire.com/media/1579538/Emergen_Research_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.